Skip to content
Meta-analysis Open access

Conserved hepatic RNA signatures across multiple cohorts reveal novel mechanistic clues for advanced fibrosis in human MASLD

Sep 2026 · Hepatology Communications · Vol 10 · 0 citations · 98 references
Medicine

Abstract

Background: Fibrosis development in patients with metabolic dysfunction–associated steatotic liver disease (MASLD) is a key indicator of disease progression and clinical outcome. Bulk and single-cell transcriptomics on human tissue have advanced understanding of fibrosis progression, but interstudy heterogeneity and limited sample size hinder the identification of consistent and targetable fibrogenic mechanisms. Methods: To identify conserved fibrogenic mechanisms, we performed a comprehensive meta-analysis of hepatic transcriptomic data with fibrosis stage characterized from ~1000 patients with MASLD. Results: Our meta-analysis revealed 846 differentially regulated genes associated with fibrosis progression (F3–4 vs. F0–1). Pathway analysis showed that these genes are involved in matrix organization (THBS2, ADAMTSL2), inflammation (CXCL6, CCL19), solute transport (SLC13A5, SLC16A10), and metabolism (AADAT, GRAMD1B). scRNA-seq-based deconvolution revealed increased proportions of immune (CD4+ T cells), endothelial (HA endo cells), and mesenchymal (myofibroblasts) cell types, and loss of LSECs in patients with advanced fibrosis in the meta-analysis. Finally, analysis of ligand–receptor pairs identified putative cell–matrix interactions (MMP7–CDH6), cell signaling (PDGFD–PDGFRA), and immune cell interactions (ANXA1–FPR1) associated with fibrosis conserved across multiple datasets and enriched in patients with fibrosis. Conclusions: We identified conserved transcriptomic changes and gene networks in patients with advanced fibrosis, as well as putative ligand–receptor interactions that facilitate cell–cell interactions that drive fibrosis. These findings will inform mechanistic studies and the development of anti-fibrotic therapies.

Read PDF

Similar papers

Open access Sep 2026

A Conserved Macrophage-to-Hepatic Stellate Cell PDGF Axis in Human MASH Identified by Multi-Cohort sc/snRNA-Seq Re-Analysis

The critically re-evaluated human liver single-nucleus RNA-sequencing data using a rigorous per-donor statistical framework to dissociate invariant biological signals from technical artifacts and establish a reproducibility-first standard for single-cell translational research.

H. Ling, P. Qiu, Yan-Zhu Hu · 0 citations
Open access Sep 2026

Multi-omics and machine learning-driven identification of PTM-related potential biomarkers and therapeutic insights in MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) is biologically heterogeneous and lacks sufficiently validated molecular biomarkers for disease characterization. Post-translational modification (PTM)-related genes may link metabolic stress to lipid dysregulation and inflammation, but their relevance...

Q. Yao, Xuan-Chong Zhong, Jia-Wei Chen et al. · 0 citations
Aug 2026

Machine Learning Analysis of Single-Cell Transcriptomics Identifies a B-Cell-Associated Fibroblast Signature Predictive of Renal Fibrosis Severity.

A validated machine-learning -derived transcriptomic signature that reflects the immune-stromal dynamics of renal fibrosis and implicates B-cell-mediated fibroblast activation as a promising diagnostic biomarker and a potential therapeutic target is presented.

S. Fazeli, A. Javanmard · 0 citations
Open access Sep 2026

Arhgap25 Promotes Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Driving Kupffer Cell Polarization via Activation of the AKT/mTOR Signaling Pathway.

BACKGROUND Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading global health burden, yet the regulatory nodes linking hepatic immune dysregulation to metabolic perturbations remain incompletely understood. METHODS We integrated bulk and single-cell RNA sequencing (scRNA-seq) to identify core...

Yan Wang, Shuang-Shuang Lu · 0 citations
Open access Aug 2026

Network-based meta-analysis maps stage-dependent molecular programs in MASLD through MASLD-META NETWORK application

Metabolic dysfunction-associated steatotic liver disease (MASLD), the leading cause of chronic liver pathologies worldwide, represents a growing clinical burden. Its diagnosis remains reliant on liver biopsy that limits early detection and the ability to capture molecular changes across disease progression. A systemati...

Eren Kumak, Thomas Darde, Ozlen Konu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.